TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. (Q41813518)
Jump to navigation
Jump to search
scientific article published on 17 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. |
scientific article published on 17 September 2009 |
Statements
TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p (English)
L P Gondek
N Bejanyan
R Tiu
J Huh
K S Theil
C O'Keefe
M A McDevitt
J P Maciejewski
17 September 2009
1 reference
1 reference
1 reference